
31 March 2022
Love Hemp Group PLC / Market: AQSE
LOVE HEMP GROUP PLC
("Love Hemp" or the "Company"; together with its subsidiary, the "Group")
Interim Results
Love Hemp Group PLC, the brand-led consumer goods company focussed on CBD health and wellness solutions, is pleased to announce its unaudited interim results for the six months ended 31 December 2021 (the "Period").
Highlights:
· Revenue of £1,736,817, down from £2,379,144 for the previous period.
· Gross margin of 20% down from 48% for the previous period, (see notes below).
· Reduction in Revenue because of repositioning product line and brand away from discounting.
· Reduction in gross margin due to some one-time costs and due to increased costs with brand building.
· Increase in Operating Loss for the Period to £5,085,143 compared to the previous period of £1,019,858, (see notes).
· Robust product delivery despite supply chain issues caused by the pandemic.
· Launch of first national media campaign (the "Campaign") starring Anthony Joshua, OBE, across TV, print and outdoor advertising.
Chairman's Statement:
This update outlines the progress that Love Hemp has made during the first half of this financial year.
The financial performance of the Company in the first half of FY22 is disappointing but reflects the planned and significant investment Love Hemp has made in marketing and brand building. Included in this are the administration costs associated with the Licensing Agreement with the UFC and the agreement with Anthony Joshua as Brand Ambassador amongst additional key product and brand development costs. The quantum of these costs are a long term investment which the Board has approved to build Love Hemp into one of the UK's best known CBD and Wellness companies. As a consumer, brand based product, this investment is expected to build value during the next five years and early signs of this value were seen with significant sales growth towards the end of the reporting period and as a result of the media campaign the Company ran in November and December 2021.
In addition to the marketing and brand investments made, a number of operational actions were also taken during the period which, when combined, will result in substantial ongoing operational and marketing cost savings. The Company has now established a system to measure the success of its marketing efforts which it will use to measure the return on investment going forward. All of these cost savings going forward better position the Company for future sales growth expected on the back of these marketing investments. One such action has been the consolidation and move from 2 facilities to 1 centralised manufacturing and office facility based in Croydon which is expected to save over £300,000 through direct and indirect savings per annum.
The Gross Margin of 20% is an unacceptable financial performance for the Group and is currently subject to a detailed review by the Board of the sales channels, pricing, promotional activities and the cost of sales associated with each product and sales channel. Some of the impact on the Gross Margin is as a result of cyclical activity and weaker economies of scale. This will naturally evolve as the Company grows, however the outcome of this review and subsequent actions will be reflected during the second half of FY22 and reported by the Company in due course.
The total loss of £5,128,456, of which approximately £2.4m are non-cash and accounting treatments, for the Group reflects the investments described above and some of the operational restructuring to reduce operating costs going forward. The Board is committed to driving profitability through higher sales growth and improved operational performance and looks forward to updating shareholders of these plans.
The cash position of the Company has been significantly improved following the post-period financing announced on 8 February 2022 with a total of £2.060m being raised. During this time the Company also secured further distribution deals with Deliveroo and eBay UK to add to the high-profile deal announced with Amazon. Love Hemp has also been recognised in the Commercial Cannabis Awards and Beauty Shortlist Awards for our quality products.
The Company continues to work towards an up-listing to the London Stock Exchange Main Market and will update shareholders with the timing for this once the Board has completed its strategic and operational review. As part of these preparations the Company has been able to attract additional independent non-executive directors to the Board in Graham Mullis and Garry Cook who are already having an impact by providing strategic and operational challenge with additional rigour and governance to the Company
I, along with the Board, look forward to steering Love Hemp through the significant number of growth opportunities that the Board believes exist for the Company and I would like to thank our shareholders and employees as we progress on this journey.
Financials
Love Hemp is a growth company in the FMCG space and as such is still developing its infrastructure for growth in the future. The gross margin during the period ended 31 December 2021, was 20%. This was low compared to the previous period ended 31 December 2020, which had a gross profit margin of 48%. The reduction in gross margin is partly as a result of a few one-time items. In the annual accounts which were presented for the period ending 30 June 2021, the gross margin had reduced to 29%, a more realistic ratio. One-time events impacting this period include;
a. Bad debts of £100,000 which accounting treatment required to be placed in the cost of goods.
b. Surplus inventory carrying over into the second half of the year, or January 2022, has the effect of surplus raw materials to that period. Estimated £150,000 as part of the declared inventory.
Reducing these amounts from Costs of Goods in turn has an adjusted positive impact on the gross profit and demonstrates an improved underlying gross margin of 35%. This performance, however, will be reviewed by the Board and actions taken to drive improvements going forward. The company had £484,641 of raw materials and finished product in inventory as of 31 December 2021.
· Gross revenue for the six-month period ended 31 December 2021 was £1,736,817 or 20% gross margin, (six months ended 31 December 2020: £2,379,144 or 48% gross margin)
· For the six-month period ended 31 December 2021 the Group reported a pre-tax loss of £5,128,456 of which approximately £2.4m was non cash attributes, (restated loss reported for the six months ended 31 December 2020: £1,153,750).
· The Group's net cash balance as at 31 December 2021 was £83,113 (30 June 2021: £925,921).
Responsibility Statement
We confirm that to the best of our knowledge:
· the interim financial statements have been prepared in accordance with International Accounting Standards 34, Interim Financial Reporting, in conformity with the requirements of the Companies Act 2006;
· the interim financial statements give a true and fair view of the assets, liabilities, financial position and loss of the Group;
· the Interim report includes a fair review of the information required by DTR 4.2.7R of the Disclosure and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the set of interim financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year; and
· the Interim report includes a fair review of the information required by DTR 4.2.8R of the Disclosure and Transparency Rules, being the information required on related party transactions.
The interim report was approved by the Board of Directors and the above responsibility statement was signed on its behalf by:
Andrew Male
Chairman and Director
31 March 2022
For further information please contact:
Andrew Male
|
|
|
|
AQSE Corporate Adviser Mark Anwyl Peterhouse Capital Limited +44 (0) 20 7469 0930 | Financial PR Tim Blythe Alice McLaren +44 (0) 207 318 3205 lovehemp@blytheray.com
|
Financial Advisor
Rupert Fane
Nilesh Patel
H&P Advisory Limited
+44 (0) 20 7907 8500
For more information on Love Hemp Group please visit: www.lovehempgroup.com
LOVE HEMP GROUP PLC CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION
PERIOD ENDED 31 DECEMBER 2021
UNAUDITED
|
| Group | ||
|
| As at 31 December 2021 (Unaudited) | As at 30 June 2021 (Audited) | |
| Note |
| £ | |
Non-current assets |
|
|
| |
Property, plant and equipment |
| 373,125 | 310,324 | |
Right of use assets |
| 1,140,355 | 1,084,463 | |
Goodwill |
| 400,000 | 400,000 | |
Intangible assets | 5 | 1,465,454 | 1,658,408 | |
Other receivables | 6 | 3,097,915 | 4,191,297 | |
|
| 6,476,849 | 7,644,492 | |
Current assets |
|
|
| |
Inventories |
| 484,641 | 572,033 | |
Trade and other receivables | 6 | 3,150,185 | 4,167,093 | |
Cash and cash equivalents |
| 83,113 | 925,921 | |
|
| 3,717,939 | 5,665,047 | |
Total assets |
| 10,194,788 | 13,309,539 | |
|
|
|
| |
Current liabilities |
|
|
| |
Trade and other payables | 7 | 2,492,375 | 1,609,266 | |
Lease liability |
| 218,391 | 180,930 | |
Borrowings |
| 359,216 | 67,329 | |
|
| 3,069,982 | 1,857,525 | |
Non-current liabilities |
|
|
| |
Lease liability |
| 828,526 | 821,431 | |
Borrowings |
| 152,256 | 231,245 | |
|
| 980,782 | 1,052,676 | |
Total liabilities |
| 4,050,764 | 2,910,201 | |
Net assets |
| 6,144,024 | 10,399,338 | |
|
|
|
| |
Equity |
|
|
| |
Share capital |
| 9,422,486 | 8,291,450 | |
Share premium |
| 17,007,570 | 16,285,464 | |
Shares to be issued |
| - | 980,000 | |
Share option reserve |
| 2,160,226 | 2,160,226 | |
Retained earnings |
| (22,446,258) | (17,317,802) | |
Total Equity |
| 6,144,024 | 10,399,338 | |
The accompanying notes are an integral part of these consolidated interim financial statement
CONSOLIDATED INTERIM STATEMENT OF COMPREHENSIVE INCOME
PERIOD ENDED 31 DECEMBER 2021 UNAUDITED
|
|
| ||
|
| Six months ended | Six months ended | |
|
| 31 December 2021 (Unaudited) | 31 December 2020 (Restated) (Audited) | |
|
| £ | £ | |
Revenue |
| 1,736,817 | 2,379,144 | |
Cost of goods sold |
| (1,378,965) | (1,228,502) | |
Gross profit |
| 357,852 | 1,150,642 | |
Administrative expenses |
| (5,472,563) | (2,772,614) | |
Other gains / (losses) |
| 15,079 | 597,780 | |
Foreign Exchange |
| 14,489 | 4,334 | |
Operating Loss |
| (5,085,143) | (1,019,858) | |
Finance Costs |
| (43,313) | (133,892) | |
Loss before taxation |
| (5,128,456) | (1,153,750) | |
Income tax |
| - | - | |
Net and comprehensive loss for the period |
| (5,128,456) | (1,153,750) | |
Basic and Diluted Earnings Per Share attributable to owners of the parent (expressed in pence per share) |
| (0.61) | (0.59) | |
|
|
|
| |
|
| Six months ended | Six months ended | |
|
| 31 December 2021 (Unaudited) | 31 December 2020 (Audited) | |
|
| £ | £ | |
Other Comprehensive Income: |
|
|
| |
Items that may be subsequently reclassified to profit or loss |
|
|
| |
Currency translation differences |
| - | - | |
Other comprehensive income for the period, net of tax |
| (5,128,456) | (1,153,750) | |
Total Comprehensive Income attributable to owners of the parent |
| (5,128,456) | (1,153,750) | |
The accompanying notes are an integral part of these consolidated interim financial statements. The consolidated statement of comprehensive income has been prepared on the basis that all operations are continuing operations.
LOVE HEMP GROUP PLC CONSOLIDATED INTERIM STATEMENT OF CHANGES IN EQUITY
PERIOD ENDED 31 DECEMBER 2021
UNAUDITED
| Share capital | Share premium | Shares to be issued | Share option reserve | Retained earnings | Total | ||
| £ | £ | £ | £ | £ | £ | ||
Balance as at 1 July 2020 | 1,456,007 | 4,661,576 | 2,251,845 | 968,568 | (12,751,059) | (3,413,063) | ||
Prior period restatement | - | - | - | - | (268,736) | (268,736) | ||
Balance as at 1 July 2020 (restated) | 1,456,007 | 4,661,576 | 2,251,845 | 968,568 | (13,019,795) | (3,681,799) | ||
Loss for the period | - | - | - | - | (1,153,750) | (1,153,750) | ||
Total comprehensive loss for the period | - | - | - | - | (1,153,750) | (1,153,750) | ||
Issue of shares and shares to be issued | 845,191 | 3,775,116 | (2,251,845) | - | - | 2,368,462 | ||
Share-based compensation | - | - | - | 887,248 | - | 887,248 |
| |
Total transactions with owners, recognised directly in equity | 845,191 | 3,775,116 | (2,251,845) | 887,248 | - | 3,255,710 | ||
Balance as at 31 December 2020 (Restated) | 2,301,198 | 8,436,692 | - | 1,855,816 | (14,173,545) | (1,579,839) | ||
| Share capital | Share premium | Shares to be issued | Share option reserve | Retained earnings | Total | ||
| £ | £ | £ | £ | £ | £ | ||
Balance as at 1 July 2021 | 8,291,450 | 16,285,464 | 980,000 | 2,160,226 | (17,317,802) | 10,399,338 | ||
Loss for the period | - | - | - | - | (5,128,456) | (5,128,456) | ||
Total comprehensive loss for the period | - | - | - | - | (5,128,456) | (5,128,456) | ||
Issue of shares and shares to be issued | 1,131,036 | 862,106 | (980,000) | - | - | 1,013,142 | ||
Issue costs |
| (140,000) |
|
|
| (140,000) |
| |
Total transactions with owners, recognised directly in equity | 1,131,036 | 722,106 | (980,000) | - | - | 873,142 | ||
Balance as at 31 December 2021 | 9,422,486 | 17,007,570 | - | 2,160,226 | (22,446,258) | 6,144,024 | ||
|
|
|
|
|
|
| ||
The accompanying notes are an integral part of these consolidated interim financial statements.
LOVE HEMP GROUP PLC STATEMENT OF CASH FLOWS
SIX MONTHS ENDED 31 DECEMBER 2021
UNAUDITED
|
|
|
|
| |
|
|
| For the period ended 31 December 2021 (Unaudited) | For the period ended 31 December 2020 (Restated) (Audited) | |
|
|
| £ | £ | |
Cash flows from operating activities |
|
|
|
| |
Net loss for the year |
|
| (5,128,456) | (1,153,750) | |
Adjustments for: |
|
|
|
| |
Depreciation and amortisation |
|
| 314,917 | 214,310 | |
Other losses |
|
| - | 8,465 | |
Other gains |
|
| - | (82,534) | |
Share based payments |
|
| - | 887,248 | |
Accretion and interest |
|
| 33,874 | 180,716 | |
Shares issued for services |
|
| 951,939 | 49,697 | |
Derivative fair value adjustment |
|
| - | (449,831) | |
(Increase)/decrease in trade and other receivables |
|
| 1,807,939 | (346,685) | |
(Increase)/decrease in inventories |
|
| 87,393 | 446,340 | |
(Decrease)/increase in trade and other payables |
|
| 1,007,089 | (239,366) | |
Net cash flows from operating activities |
|
| (925,305) | (485,390) | |
|
|
|
|
| |
Investing activities |
|
|
|
| |
Purchase of property, plant and equipment |
|
| (106,182) | (58,259) | |
Net cash used in investing activities |
|
| (106,182) | (58,259) | |
|
|
|
|
| |
Financing activities |
|
|
|
| |
Proceeds from share issue |
|
| 99,570 | 381,143 | |
Lease payments |
|
| (109,414) | (90,460) | |
Loans received |
|
| 273,369 | 178,687 | |
Loan repayments |
|
| (74,846) | (47,290) | |
Net cash used in financing activities |
|
| 188,679 | 422,080 | |
|
|
|
|
| |
Net increase/(decrease) in cash and cash equivalents |
|
| (842,808) | (121,569) | |
Cash and cash equivalents at beginning of period |
|
| 925,921 | 200,546 | |
Cash and cash equivalents and end of period |
|
| 83,113 | 78,977 | |
The accompanying notes are an integral part of these consolidated interim financial statements.
Major non-cash transactions:
On 22 November 2021 the Company issued 23,746,371 Ordinary shares of £0.01 each for £0.016 per share for a total consideration of £402,500. Further the Company issued 3,833,342 Ordinary shares of £0.01 each for £0.035 per share for a total consideration of £134,166 to the same service provider.
On 22 November 2021 the Company issued 8,257,143 Ordinary shares of £0.01 each for £0.035 per share for a total consideration of £289,000.
On 21 December 2021 the Company issued 65,000,000 Ordinary shares of £0.01 each for £0.015 per share for a total consideration of £975,000 in order to settle the final portion of the deferred consideration outstanding to the vendors of Love Hemp Limited.
1. GENERAL INFORMATION
Love Hemp Group Plc (formerly World High Life plc) was incorporated by in England and Wales on 30 January 2019 with registration number 11797850 under the Companies Act 2006. The limited company reregistered as a public company on 6 August 2019, and thus became World High Life PLC (the "Company") on the same date. The Company changed its name to Love Hemp Group PLC on 27 February 2021. The Company's head office and registered and records office address is Suite 1, 15 Ingestre Place, London, W1F 0DU.
The Company is focused on developing business opportunities in the CBD Health and Wellness market, as well as the Regulated Medicinal Cannabis market in the UK and Europe. The Company's wholly owned subsidiary Love Hemp Ltd is a leading CBD products company based in the UK.
2. BASIS OF PRESENTATION
The condensed consolidated interim financial statements for the six-month period ended 31 December 2021 have been prepared in accordance with IAS 34 "Interim Financial Statements" as adopted by the United Kingdom and the Disclosure and Transparency Rules of the UK Financial Conduct Authority. The condensed interim financial statements should be read in conjunction with the annual financial statements for the period ended 30 June 2021, which have been prepared in accordance with International Financial Reporting Standards (IFRS) in conformity with the requirements of the Companies Act 2006.
The interim financial information set out above does not constitute statutory accounts within the meaning of the Companies Act 2006. It has been prepared on a going concern basis in accordance with the recognition and measurement criteria of International Financial Reporting Standards (IFRS) in conformity with the requirements of the Companies Act 2006.
The condensed consolidated interim financial statements for the six-month period ended 31 December 2021 were approved by the Board of Directors on 31 March 2022.
3. SIGNIFICANT ACCOUNTING POLICIES
The accounting policies applied in preparing these financial statements are in terms of IFRS and are consistent with those applied in the previous annual consolidated financial statements for the year ended 30 June 2021.
It has been prepared assuming that the Group will continue as a going concern in accordance with the recognition and measurement criteria of IFRS in conformity with the requirements of the Companies Act 2006.
Under this assumption, an entity is ordinarily viewed as continuing in business for the foreseeable future with neither the intention nor necessity of liquidation, ceasing trading or seeking protection from creditors for at least 12 months from the date of the signing of the financial statements.
An assessment of going concern is made by the Directors at the date the Directors approve the interim financial statements, taking into account the relevant facts and circumstances at that date including:
• Review of profit and cash flow forecasts;
• Review of actual results against forecast;
• Timing of cash flows;
• Financial or operational risks; and
• The impact of COVID-19
The Directors have reviewed forecasts which display significant growth in sales transforming the business into cashflow profitability over the following period. The Directors believe funds can continue to be raised from the capital markets to support any working capital shortfalls and expect to do so in the next 12 months. The Group has adequately planned and, where relevant, put in place mitigation strategies for the impacts of COVID-19. On the basis of the above, and with the expectation of external financing being sourced, the Directors have a reasonable expectation that the Group and Company have adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis of accounting in preparing the interim financial statements.
The statutory consolidated financial statements for the period to 30 June 2021, approved by the Board of Directors on 12 December 2021, have been reported on by the Group's auditors and delivered to Companies House. The report of the auditors on those financial statements was unqualified. The auditors made reference to the existence of a material uncertainty in relation to going concern within that audit report, to which we draw your attention.
4. ADOPTION OF RECENT ACCOUNTING PRONOUCEMENTS
(a) New and amended standards mandatory for the first time for the financial periods beginning on or after 1 July 2021
As at 1 July 2021, there were no Standards, Interpretations and Amendments which had been issued but were not effective for the period ended 30 June 2021 that are expected to materially impact the Group's Financial Statements.
b) New standards, amendments and interpretations in issue but not yet effective or not yet endorsed and not early adopted
Standards, amendments and interpretations that are not yet effective and have not been early adopted are as follows:
Standard | Impact on initial application | Effective date |
IFRS 3 (amendments) | Reference to Conceptual Framework | 1 January 2022 |
IAS 37 (amendments) | Onerous contracts | 1 January 2022 |
IAS 16 (amendments) | Proceeds before intended use | 1 January 2022 |
Annual improvements | 2018-2020 Cycle | 1 January 2022 |
IAS 8 (amendments) | Accounting estimates | 1 January 2023 |
IAS 1 (amendments) | Classification of Liabilities as Current or Non-Current. | 1 January 2023 |
The Group is evaluating the impact of the new and amended standards above which are not expected to have a material impact on future Group financial statements.
5. INTANGIBLE ASSETS
| Customer Relationships £ | Brand £ | Trademarks £ | Total £ |
30 June 2021 | 591,169 | 1,056,937 | 10,302 | 1,658,408 |
Amortisation | (68,750) | (122,916) | (1,288) | (192,954) |
31 December 2021 | 522,419 | 937,021 | 9,014 | 1,465,454 |
In the year ended 30 June 2021 a purchase price allocation exercise relating to the purchase of Love Hemp Ltd by the Company was completed as per the requirements of IFRS 3 which valued the Group's customer relationships and brand at £2,300,000. This has been adjusted for as a restatement as disclosed in Note 8.
6. TRADE RECEIVABLES AND OTHER RECIEVABLES
Current: | Group | |
| 31 December 2021 £ | 30 June 2021 £ |
Trade receivables | 369,282 | 189,869 |
Prepayments | 2,330,612 | 3,119,691 |
Placing proceeds receivable | 105,000 | 279,753 |
VAT receivables | 223,355 | 498,260 |
Other receivables | 121,936 | 79,520 |
| 3,150,185 | 4,167,093 |
Non-Current:
| Group | |
| 31 December 2021 £ | 30 June 2021 £ |
Prepayments | 3,097,915 | 4,191,297 |
| 3,097,915 | 4,191,297 |
7. TRADE PAYABLES AND OTHER PAYABLES
Current: | Group | |
| 31 December 2021 £ | 30 June 2021 £ |
Trade payables | 1,849,112 | 979,174 |
Accrued liabilities | 395,134 | 352,861 |
Tax and payroll | 168,844 | 248,211 |
Other creditors | 79,285 | 29,020 |
| 2,492,375 | 1,609,266 |
8. RESTATEMENT FOLLOWING PURCHASE PRICE ALLOCATION EXERCISE
During the year ended 30 June 2021, a purchase price allocation exercise relating to the purchase of Love Hemp Ltd by the Company was completed. This exercise led to two separate classes of intangible fixed assets, the Love Hemp brand and its customer relationships, being assigned a total value of £2,300,000.
As required under IFRS 3, the comparative figures have been amended to account for the identified intangible fixed assets as if the purchase price allocation exercise took place on the date of acquisition.
As a result, goodwill has been reduced by £2,300,000 and amortisation has been recognised in respect of the intangible fixed assets for the period from acquisition on a straight line basis based on the intangible fixed assets having a useful economic life of 6 years.
The impact of the restatement for the year ended 30 June 2020 in respect of the classification of the goodwill and intangibles are as follows:
| 30 June 2020 as presented £ |
Restatement £ | 30 June 2020 restated £ |
Goodwill | 2,700,000 | (2,300,000) | 400,000 |
Intangibles | - | 2,031,264 | 2,031,264 |
Amortisation through profit or loss | - | 268,736 | 268,736 |
The impact of the restatement for the six-month period ended 31 December 2020 is as follows:
| 31 December 2020 as presented £ |
Restatement £ | 31 December 2020 restated £ |
Amortisation through profit or loss | - | 191,579 | 191,579 |
9. SUBSEQUENT EVENTS
On 8 February 2022, the Company issued 206,000,000 Ordinary shares for a price of £0.01 per share for a total value of £2,060,000 for cash.
On 21 February 2022, the Company issued 50,555,750 Ordinary shares at a price of £0.01 per share for a total value of £505,557 in lieu of debt repayments.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.